Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
Ann Neurol
; 89(4): 780-789, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33480077
Full text:
1
Database:
MEDLINE
Main subject:
COVID-19
/
Hospitalization
/
Immunosuppressive Agents
/
Multiple Sclerosis
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Neurol
Year:
2021
Type:
Article
Affiliation country:
Italy